James Christopher Costello

Cedars-Sinai Medical Center

NIH Rank #26880
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$592.1K
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#26,880
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $592.1K across 4 grants · National rank #26880.

Top grants by award amount

James Christopher Costello's NIH grant portfolio, ranked by award amount.

  • 5R01CA268055-03R01
    NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
    $476.6K
    award amount
  • 3R01CA268055-03S1R01
    NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
    $81K
    award amount
  • 1R13CA291000-01R13
    Systems Approaches to Cancer Biology Meeting
    $25.4K
    award amount
  • 3R01CA268055-02S1R01
    Investigating NPEPPS-mediated feedback between bladder cancer cells and peripheral neurons as a mechanism of cisplatin resistance
    $9.2K
    award amount

Affiliations

Institutions that have administered grants for James Christopher Costello.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Cedars-Sinai Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    Multi-Institutional Research
    Awards at 2 institutions